GlassScriptPhysician profile
Lisa Hicks
NPI 1497021414
$5,647.79
in general payments reported to CMS, 2019-2025
27 companies · $1,571 in 2025
The $1,571 reported for 2025 was more than what 98% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $467 · 2022: $1,410 · 2023: $1,050 · 2024: $1,149 · 2025: $1,571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,482 · Education: $289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,481.76 |
| Education | $289.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $1,258.75 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $947.92 | 2021-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $831.54 | 2022-2025 | Tezspire, Fasenra |
| Genzyme Corporation | $756.67 | 2022-2025 | |
| Qol Medical, LLC | $341.33 | 2021-2022 | |
| Amgen INC. | $280.39 | 2022-2025 | Tezspire |
| Ucb, INC. | $251.74 | 2021-2023 | Cimzia |
| Xeris Pharmaceuticals, INC. | $128.15 | 2021-2023 | Gvoke Hypopen |
| Harmony Biosciences LLC | $103.71 | 2024-2025 | |
| Corium, LLC | $80.34 | 2022-2024 | Azstarys |
| Alcresta Therapeutics, INC. | $76.00 | 2025 | Relizorb |
| Ascendis Pharma Endocrinology INC | $73.18 | 2022-2025 | Skytrofa |
| Eisai INC. | $62.65 | 2021-2022 | |
| Genentech USA, INC. | $60.35 | 2021-2025 | Xolair |
| Kyowa Kirin, INC. | $52.31 | 2023-2024 | Crysvita |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aquestive Therapeutics, INC. | $52.23 | 2021-2022 | |
| Biogen, INC. | $44.53 | 2022 | |
| Pfizer INC. | $33.05 | 2024 | |
| Glaxosmithkline, LLC. | $30.21 | 2021-2022 | |
| Zogenix INC. | $30.16 | 2021 | |
| Abbvie INC. | $28.06 | 2023-2025 | |
| Inspire Medical Systems, INC. | $27.06 | 2025 | Inspire |
| Ultragenyx Pharmaceutical INC. | $24.88 | 2022 | |
| Neurelis, INC. | $23.96 | 2022 | |
| Eton Pharmaceuticals, INC. | $18.00 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.81 | 2021 | |
| Baxter Healthcare | $14.81 | 2024 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.